185 related articles for article (PubMed ID: 29119969)
1. Tumor-targeting efficacy of a BF211 prodrug through hydrolysis by fibroblast activation protein-α.
Chai XP; Sun GL; Fang YF; Hu LH; Liu X; Zhang XW
Acta Pharmacol Sin; 2018 Mar; 39(3):415-424. PubMed ID: 29119969
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast Activation Protein α Activated Tripeptide Bufadienolide Antitumor Prodrug with Reduced Cardiotoxicity.
Deng LJ; Wang LH; Peng CK; Li YB; Huang MH; Chen MF; Lei XP; Qi M; Cen Y; Ye WC; Zhang DM; Chen WM
J Med Chem; 2017 Jul; 60(13):5320-5333. PubMed ID: 28595013
[TBL] [Abstract][Full Text] [Related]
3. A novel FAPα-based Z-Gly-Pro epirubicin prodrug for improving tumor-targeting chemotherapy.
Wang J; Li Q; Li X; Yuan W; Huang S; Cai S; Xu J
Eur J Pharmacol; 2017 Nov; 815():166-172. PubMed ID: 28919026
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the tumor targeting of a FAPα-based doxorubicin prodrug.
Huang S; Fang R; Xu J; Qiu S; Zhang H; Du J; Cai S
J Drug Target; 2011 Aug; 19(7):487-96. PubMed ID: 21284542
[TBL] [Abstract][Full Text] [Related]
5. A Novel Bufalin Derivative Exhibited Stronger Apoptosis-Inducing Effect than Bufalin in A549 Lung Cancer Cells and Lower Acute Toxicity in Mice.
Liu M; Feng LX; Sun P; Liu W; Wu WY; Jiang BH; Yang M; Hu LH; Guo DA; Liu X
PLoS One; 2016; 11(7):e0159789. PubMed ID: 27459387
[TBL] [Abstract][Full Text] [Related]
6. Enhanced anti-tumor efficiency of gemcitabine prodrug by FAPα-mediated activation.
Sun J; Yang D; Cui SH; Zhang HT; Fu Y; Wang JC; Zhang Q
Int J Pharm; 2019 Mar; 559():48-57. PubMed ID: 30677483
[TBL] [Abstract][Full Text] [Related]
7. Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha.
Aertgeerts K; Levin I; Shi L; Snell GP; Jennings A; Prasad GS; Zhang Y; Kraus ML; Salakian S; Sridhar V; Wijnands R; Tennant MG
J Biol Chem; 2005 May; 280(20):19441-4. PubMed ID: 15809306
[TBL] [Abstract][Full Text] [Related]
8. Iterative design of emetine-based prodrug targeting fibroblast activation protein (FAP) and dipeptidyl peptidase IV DPPIV using a tandem enzymatic activation strategy.
Akinboye ES; Brennen WN; Rosen DM; Bakare O; Denmeade SR
Prostate; 2016 Jun; 76(8):703-14. PubMed ID: 26835873
[TBL] [Abstract][Full Text] [Related]
9. Introduction of Z-GP scaffold into procarbazine reduces spermatoxicity and myelosuppression.
Wang R; Zhang C; Zheng C; Li H; Xie X; Jin Y; Liu Z; Chen H
Bioorg Chem; 2019 Mar; 83():461-467. PubMed ID: 30448724
[TBL] [Abstract][Full Text] [Related]
10. Bufalin derivative BF211 inhibits proteasome activity in human lung cancer cells in vitro by inhibiting β1 subunit expression and disrupting proteasome assembly.
Sun P; Feng LX; Zhang DM; Liu M; Liu W; Mi T; Wu WY; Jiang BH; Yang M; Hu LH; Guo DA; Liu X
Acta Pharmacol Sin; 2016 Jul; 37(7):908-18. PubMed ID: 27238210
[TBL] [Abstract][Full Text] [Related]
11. Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug.
Brennen WN; Rosen DM; Wang H; Isaacs JT; Denmeade SR
J Natl Cancer Inst; 2012 Sep; 104(17):1320-34. PubMed ID: 22911669
[TBL] [Abstract][Full Text] [Related]
12. Over-expression of fibroblast activation protein alpha increases tumor growth in xenografts of ovarian cancer cells.
Yang L; Ma L; Lai D
Acta Biochim Biophys Sin (Shanghai); 2013 Nov; 45(11):928-37. PubMed ID: 24028972
[TBL] [Abstract][Full Text] [Related]
13. Surfactant Assisted Rapid-Release Liposomal Strategies Enhance the Antitumor Efficiency of Bufalin Derivative and Reduce Cardiotoxicity.
Gao L; Zhang L; He F; Chen J; Zhao M; Li S; Wu H; Liu Y; Zhang Y; Ping Q; Hu L; Qiao H
Int J Nanomedicine; 2021; 16():3581-3598. PubMed ID: 34079251
[TBL] [Abstract][Full Text] [Related]
14. Toxicological profile and safety pharmacology of a single dose of fibroblast activation protein-α-based doxorubicin prodrug: in-vitro and in-vivo evaluation.
Huang S; Zhang Y; Zhong J; Pan Y; Cai S; Xu J
Anticancer Drugs; 2018 Mar; 29(3):253-261. PubMed ID: 29346131
[TBL] [Abstract][Full Text] [Related]
15. BF211, a derivative of bufalin, enhances the cytocidal effects in multiple myeloma cells by inhibiting the IL-6/JAK2/STAT3 pathway.
Wu XY; Tian F; Su MH; Wu M; Huang Y; Hu LH; Jin L; Zhu XJ
Int Immunopharmacol; 2018 Nov; 64():24-32. PubMed ID: 30145467
[TBL] [Abstract][Full Text] [Related]
16. Promotion of Cellular Growth and Motility Is Independent of Enzymatic Activity of Fibroblast Activation Protein-α.
Lv B; Xie F; Zhao P; Ma X; Jiang WG; Yu J; Zhang X; Jia J
Cancer Genomics Proteomics; 2016; 13(3):201-8. PubMed ID: 27107062
[TBL] [Abstract][Full Text] [Related]
17. Activatable near-infrared fluorescent probe for in vivo imaging of fibroblast activation protein-alpha.
Li J; Chen K; Liu H; Cheng K; Yang M; Zhang J; Cheng JD; Zhang Y; Cheng Z
Bioconjug Chem; 2012 Aug; 23(8):1704-11. PubMed ID: 22812530
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis.
Acharya PS; Zukas A; Chandan V; Katzenstein AL; Puré E
Hum Pathol; 2006 Mar; 37(3):352-60. PubMed ID: 16613331
[TBL] [Abstract][Full Text] [Related]
19. A synthetic urinary probe-coated nanoparticles sensitive to fibroblast activation protein α for solid tumor diagnosis.
Feng X; Wang Q; Liao Y; Zhou X; Wang Y; Liu W; Zhang G
Int J Nanomedicine; 2017; 12():5359-5372. PubMed ID: 28794628
[TBL] [Abstract][Full Text] [Related]
20. A Trifunctional Theranostic Ligand Targeting Fibroblast Activation Protein-α (FAPα).
Kelly JM; Jeitner TM; Ponnala S; Williams C; Nikolopoulou A; DiMagno SG; Babich JW
Mol Imaging Biol; 2021 Oct; 23(5):686-696. PubMed ID: 33721173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
